|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1992-12-7
|
|
pubmed:abstractText |
The results demonstrate that organic calcium antagonists are able to reduce epileptic activity at the level of single neurons and of neuronal populations. This holds true also for human cortical tissue. Among other observations already published this justifies the hope that calcium antagonistic agents might be useful in the treatment of human epilepsies (28).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0065-1427
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
140
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
41-6
|
|
pubmed:dateRevised |
2007-7-23
|
|
pubmed:meshHeading |
pubmed-meshheading:1332361-Animals,
pubmed-meshheading:1332361-Calcium Channel Blockers,
pubmed-meshheading:1332361-Calcium Channels,
pubmed-meshheading:1332361-Cerebral Cortex,
pubmed-meshheading:1332361-Electroencephalography,
pubmed-meshheading:1332361-Epilepsy,
pubmed-meshheading:1332361-Female,
pubmed-meshheading:1332361-Humans,
pubmed-meshheading:1332361-Injections, Intraventricular,
pubmed-meshheading:1332361-Male,
pubmed-meshheading:1332361-Neurons,
pubmed-meshheading:1332361-Pentylenetetrazole,
pubmed-meshheading:1332361-Rats,
pubmed-meshheading:1332361-Verapamil
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Epileptogenesis: contributions of calcium ions and antiepileptic calcium antagonists.
|
|
pubmed:affiliation |
Psychiatrische Universitätsklinik, Freiburg, Germany.
|
|
pubmed:publicationType |
Journal Article,
Review
|
